img

Global Goose Parvovirus Antibodies Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Agriculture

Publisher : MRA | Format : PDF

Global Goose Parvovirus Antibodies Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Goose Parvovirus Antibodies report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Goose Parvovirus Antibodies market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Individual Farming and Medium and Large Farms are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Goose Parvovirus Antibodies industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Goose Parvovirus Antibodies key manufacturers include Harbin Pharmaceutical Group, Qilu Animal Health Products Factorys, Liaoning Yikang Biological, Henan Hou Yi Group, Tianjin Ruipu and Guangzhou geleite Biotechnology, etc. Harbin Pharmaceutical Group, Qilu Animal Health Products Factorys, Liaoning Yikang Biological are top 3 players and held % sales share in total in 2022.
Goose Parvovirus Antibodies can be divided into AGP≥18, AGP≥116 and AGP≥132,, etc. AGP≥18 is the mainstream product in the market, accounting for % sales share globally in 2022.
Goose Parvovirus Antibodies is widely used in various fields, such as Individual Farming and Medium and Large Farms, etc. Individual Farming provides greatest supports to the Goose Parvovirus Antibodies industry development. In 2022, global % sales of Goose Parvovirus Antibodies went into Individual Farming filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Goose Parvovirus Antibodies market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Harbin Pharmaceutical Group
Qilu Animal Health Products Factorys
Liaoning Yikang Biological
Henan Hou Yi Group
Tianjin Ruipu
Guangzhou geleite Biotechnology
Segment by Type
AGP≥18
AGP≥116
AGP≥132

Segment by Application


Individual Farming
Medium and Large Farms

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Goose Parvovirus Antibodies market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Goose Parvovirus Antibodies, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Goose Parvovirus Antibodies industry.
Chapter 3Historical (2018-2022) and forecast (2023-2033) volume and revenue analysis of Goose Parvovirus Antibodies in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Goose Parvovirus Antibodies introduction, etc. Goose Parvovirus Antibodies Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13MRAResearch’s Conclusions of Goose Parvovirus Antibodies market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by MRAResearch.

Table of Content

1 Goose Parvovirus Antibodies Market Overview
1.1 Goose Parvovirus Antibodies Product Overview
1.2 Goose Parvovirus Antibodies Market Segment by Type
1.2.1 AGP≥1:8
1.2.2 AGP≥1:16
1.2.3 AGP≥1:32
1.3 Global Goose Parvovirus Antibodies Market Size by Type
1.3.1 Global Goose Parvovirus Antibodies Market Size Overview by Type (2018-2033)
1.3.2 Global Goose Parvovirus Antibodies Historic Market Size Review by Type (2018-2023)
1.3.3 Global Goose Parvovirus Antibodies Forecasted Market Size by Type (2024-2033)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Goose Parvovirus Antibodies Sales Breakdown by Type (2018-2023)
1.4.2 Europe Goose Parvovirus Antibodies Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Goose Parvovirus Antibodies Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Goose Parvovirus Antibodies Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Goose Parvovirus Antibodies Sales Breakdown by Type (2018-2023)
2 Global Goose Parvovirus Antibodies Market Competition by Company
2.1 Global Top Players by Goose Parvovirus Antibodies Sales (2018-2023)
2.2 Global Top Players by Goose Parvovirus Antibodies Revenue (2018-2023)
2.3 Global Top Players by Goose Parvovirus Antibodies Price (2018-2023)
2.4 Global Top Manufacturers Goose Parvovirus Antibodies Manufacturing Base Distribution, Sales Area, Product Type
2.5 Goose Parvovirus Antibodies Market Competitive Situation and Trends
2.5.1 Goose Parvovirus Antibodies Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Goose Parvovirus Antibodies Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Goose Parvovirus Antibodies as of 2022)
2.7 Date of Key Manufacturers Enter into Goose Parvovirus Antibodies Market
2.8 Key Manufacturers Goose Parvovirus Antibodies Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Goose Parvovirus Antibodies Status and Outlook by Region
3.1 Global Goose Parvovirus Antibodies Market Size and CAGR by Region: 2018 VS 2022 VS 2033
3.2 Global Goose Parvovirus Antibodies Historic Market Size by Region
3.2.1 Global Goose Parvovirus Antibodies Sales in Volume by Region (2018-2023)
3.2.2 Global Goose Parvovirus Antibodies Sales in Value by Region (2018-2023)
3.2.3 Global Goose Parvovirus Antibodies Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Goose Parvovirus Antibodies Forecasted Market Size by Region
3.3.1 Global Goose Parvovirus Antibodies Sales in Volume by Region (2024-2033)
3.3.2 Global Goose Parvovirus Antibodies Sales in Value by Region (2024-2033)
3.3.3 Global Goose Parvovirus Antibodies Sales (Volume & Value), Price and Gross Margin (2024-2033)
4 Global Goose Parvovirus Antibodies by Application
4.1 Goose Parvovirus Antibodies Market Segment by Application
4.1.1 Individual Farming
4.1.2 Medium and Large Farms
4.2 Global Goose Parvovirus Antibodies Market Size by Application
4.2.1 Global Goose Parvovirus Antibodies Market Size Overview by Application (2018-2033)
4.2.2 Global Goose Parvovirus Antibodies Historic Market Size Review by Application (2018-2023)
4.2.3 Global Goose Parvovirus Antibodies Forecasted Market Size by Application (2024-2033)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Goose Parvovirus Antibodies Sales Breakdown by Application (2018-2023)
4.3.2 Europe Goose Parvovirus Antibodies Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Goose Parvovirus Antibodies Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Goose Parvovirus Antibodies Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Goose Parvovirus Antibodies Sales Breakdown by Application (2018-2023)
5 North America Goose Parvovirus Antibodies by Country
5.1 North America Goose Parvovirus Antibodies Historic Market Size by Country
5.1.1 North America Goose Parvovirus Antibodies Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
5.1.2 North America Goose Parvovirus Antibodies Sales in Volume by Country (2018-2023)
5.1.3 North America Goose Parvovirus Antibodies Sales in Value by Country (2018-2023)
5.2 North America Goose Parvovirus Antibodies Forecasted Market Size by Country
5.2.1 North America Goose Parvovirus Antibodies Sales in Volume by Country (2024-2033)
5.2.2 North America Goose Parvovirus Antibodies Sales in Value by Country (2024-2033)
6 Europe Goose Parvovirus Antibodies by Country
6.1 Europe Goose Parvovirus Antibodies Historic Market Size by Country
6.1.1 Europe Goose Parvovirus Antibodies Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
6.1.2 Europe Goose Parvovirus Antibodies Sales in Volume by Country (2018-2023)
6.1.3 Europe Goose Parvovirus Antibodies Sales in Value by Country (2018-2023)
6.2 Europe Goose Parvovirus Antibodies Forecasted Market Size by Country
6.2.1 Europe Goose Parvovirus Antibodies Sales in Volume by Country (2024-2033)
6.2.2 Europe Goose Parvovirus Antibodies Sales in Value by Country (2024-2033)
7 Asia-Pacific Goose Parvovirus Antibodies by Region
7.1 Asia-Pacific Goose Parvovirus Antibodies Historic Market Size by Region
7.1.1 Asia-Pacific Goose Parvovirus Antibodies Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2033
7.1.2 Asia-Pacific Goose Parvovirus Antibodies Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Goose Parvovirus Antibodies Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Goose Parvovirus Antibodies Forecasted Market Size by Region
7.2.1 Asia-Pacific Goose Parvovirus Antibodies Sales in Volume by Region (2024-2033)
7.2.2 Asia-Pacific Goose Parvovirus Antibodies Sales in Value by Region (2024-2033)
8 Latin America Goose Parvovirus Antibodies by Country
8.1 Latin America Goose Parvovirus Antibodies Historic Market Size by Country
8.1.1 Latin America Goose Parvovirus Antibodies Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
8.1.2 Latin America Goose Parvovirus Antibodies Sales in Volume by Country (2018-2023)
8.1.3 Latin America Goose Parvovirus Antibodies Sales in Value by Country (2018-2023)
8.2 Latin America Goose Parvovirus Antibodies Forecasted Market Size by Country
8.2.1 Latin America Goose Parvovirus Antibodies Sales in Volume by Country (2024-2033)
8.2.2 Latin America Goose Parvovirus Antibodies Sales in Value by Country (2024-2033)
9 Middle East and Africa Goose Parvovirus Antibodies by Country
9.1 Middle East and Africa Goose Parvovirus Antibodies Historic Market Size by Country
9.1.1 Middle East and Africa Goose Parvovirus Antibodies Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
9.1.2 Middle East and Africa Goose Parvovirus Antibodies Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Goose Parvovirus Antibodies Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Goose Parvovirus Antibodies Forecasted Market Size by Country
9.2.1 Middle East and Africa Goose Parvovirus Antibodies Sales in Volume by Country (2024-2033)
9.2.2 Middle East and Africa Goose Parvovirus Antibodies Sales in Value by Country (2024-2033)
10 Company Profiles
10.1 Harbin Pharmaceutical Group
10.1.1 Harbin Pharmaceutical Group Company Information
10.1.2 Harbin Pharmaceutical Group Introduction and Business Overview
10.1.3 Harbin Pharmaceutical Group Goose Parvovirus Antibodies Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Harbin Pharmaceutical Group Goose Parvovirus Antibodies Products Offered
10.1.5 Harbin Pharmaceutical Group Recent Development
10.2 Qilu Animal Health Products Factorys
10.2.1 Qilu Animal Health Products Factorys Company Information
10.2.2 Qilu Animal Health Products Factorys Introduction and Business Overview
10.2.3 Qilu Animal Health Products Factorys Goose Parvovirus Antibodies Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Qilu Animal Health Products Factorys Goose Parvovirus Antibodies Products Offered
10.2.5 Qilu Animal Health Products Factorys Recent Development
10.3 Liaoning Yikang Biological
10.3.1 Liaoning Yikang Biological Company Information
10.3.2 Liaoning Yikang Biological Introduction and Business Overview
10.3.3 Liaoning Yikang Biological Goose Parvovirus Antibodies Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Liaoning Yikang Biological Goose Parvovirus Antibodies Products Offered
10.3.5 Liaoning Yikang Biological Recent Development
10.4 Henan Hou Yi Group
10.4.1 Henan Hou Yi Group Company Information
10.4.2 Henan Hou Yi Group Introduction and Business Overview
10.4.3 Henan Hou Yi Group Goose Parvovirus Antibodies Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Henan Hou Yi Group Goose Parvovirus Antibodies Products Offered
10.4.5 Henan Hou Yi Group Recent Development
10.5 Tianjin Ruipu
10.5.1 Tianjin Ruipu Company Information
10.5.2 Tianjin Ruipu Introduction and Business Overview
10.5.3 Tianjin Ruipu Goose Parvovirus Antibodies Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Tianjin Ruipu Goose Parvovirus Antibodies Products Offered
10.5.5 Tianjin Ruipu Recent Development
10.6 Guangzhou geleite Biotechnology
10.6.1 Guangzhou geleite Biotechnology Company Information
10.6.2 Guangzhou geleite Biotechnology Introduction and Business Overview
10.6.3 Guangzhou geleite Biotechnology Goose Parvovirus Antibodies Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Guangzhou geleite Biotechnology Goose Parvovirus Antibodies Products Offered
10.6.5 Guangzhou geleite Biotechnology Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Goose Parvovirus Antibodies Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Goose Parvovirus Antibodies Industrial Chain Analysis
11.4 Goose Parvovirus Antibodies Market Dynamics
11.4.1 Goose Parvovirus Antibodies Industry Trends
11.4.2 Goose Parvovirus Antibodies Market Drivers
11.4.3 Goose Parvovirus Antibodies Market Challenges
11.4.4 Goose Parvovirus Antibodies Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Goose Parvovirus Antibodies Distributors
12.3 Goose Parvovirus Antibodies Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of AGP≥1:8
Table 2. Major Company of AGP≥1:16
Table 3. Major Company of AGP≥1:32
Table 4. Global Goose Parvovirus Antibodies Sales by Type 2018 VS 2022 VS 2033 (US$ Million)
Table 5. Global Goose Parvovirus Antibodies Sales by Type (2018-2023) & (M Doses)
Table 6. Global Goose Parvovirus Antibodies Sales Market Share in Volume by Type (2018-2023)
Table 7. Global Goose Parvovirus Antibodies Sales by Type (2018-2023) & (US& Million)
Table 8. Global Goose Parvovirus Antibodies Market Share in Value by Type (2018-2023)
Table 9. Global Goose Parvovirus Antibodies Price by Type (2018-2023) & (US$/K Doses)
Table 10. Global Goose Parvovirus Antibodies Sales by Type (2024-2033) & (M Doses)
Table 11. Global Goose Parvovirus Antibodies Sales Market Share in Volume by Type (2024-2033)
Table 12. Global Goose Parvovirus Antibodies Sales by Type (2024-2033) & (US$ Million)
Table 13. Global Goose Parvovirus Antibodies Sales Market Share in Value by Type (2024-2033)
Table 14. Global Goose Parvovirus Antibodies Price by Type (2024-2033) & (US$/K Doses)
Table 15. North America Goose Parvovirus Antibodies Sales by Type (2018-2023) & (M Doses)
Table 16. North America Goose Parvovirus Antibodies Sales by Type (2018-2023) & (US$ Million)
Table 17. Europe Goose Parvovirus Antibodies Sales (M Doses) by Type (2018-2023)
Table 18. Europe Goose Parvovirus Antibodies Sales by Type (2018-2023) & (US$ Million)
Table 19. Asia-Pacific Goose Parvovirus Antibodies Sales (M Doses) by Type (2018-2023)
Table 20. Asia-Pacific Goose Parvovirus Antibodies Sales by Type (2018-2023) & (US$ Million)
Table 21. Latin America Goose Parvovirus Antibodies Sales (M Doses) by Type (2018-2023)
Table 22. Latin America Goose Parvovirus Antibodies Sales by Type (2018-2023) & (US$ Million)
Table 23. Middle East and Africa Goose Parvovirus Antibodies Sales (M Doses) by Type (2018-2023)
Table 24. Middle East and Africa Goose Parvovirus Antibodies Sales by Type (2018-2023) & (US$ Million)
Table 25. Global Goose Parvovirus Antibodies Sales by Company (2018-2023) & (M Doses)
Table 26. Global Goose Parvovirus Antibodies Sales Share by Company (2018-2023)
Table 27. Global Goose Parvovirus Antibodies Revenue by Company (2018-2023) & (US$ Million)
Table 28. Global Goose Parvovirus Antibodies Revenue Share by Company (2018-2023)
Table 29. Global Market Goose Parvovirus Antibodies Price by Company (2018-2023) & (US$/K Doses)
Table 30. Global Goose Parvovirus Antibodies Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Goose Parvovirus Antibodies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Goose Parvovirus Antibodies as of 2022)
Table 33. Date of Key Manufacturers Enter into Goose Parvovirus Antibodies Market
Table 34. Key Manufacturers Goose Parvovirus Antibodies Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Goose Parvovirus Antibodies Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2033
Table 37. Global Goose Parvovirus Antibodies Sales by Region (2018-2023) & (M Doses)
Table 38. Global Goose Parvovirus Antibodies Sales Market Share in Volume by Region (2018-2023)
Table 39. Global Goose Parvovirus Antibodies Sales by Region (2018-2023) & (US$ Million)
Table 40. Global Goose Parvovirus Antibodies Sales Market Share in Value by Region (2018-2023)
Table 41. Global Goose Parvovirus Antibodies Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 42. Global Goose Parvovirus Antibodies Sales by Region (2024-2033) & (M Doses)
Table 43. Global Goose Parvovirus Antibodies Sales Market Share in Volume by Region (2024-2033)
Table 44. Global Goose Parvovirus Antibodies Sales by Region (2024-2033) & (US$ Million)
Table 45. Global Goose Parvovirus Antibodies Sales Market Share in Value by Region (2024-2033)
Table 46. Global Goose Parvovirus Antibodies Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2024-2033)
Table 47. Global Goose Parvovirus Antibodies Sales by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 48. Global Goose Parvovirus Antibodies Sales by Application (2018-2023) & (M Doses)
Table 49. Global Goose Parvovirus Antibodies Sales Market Share in Volume by Application (2018-2023)
Table 50. Global Goose Parvovirus Antibodies Sales by Application (2018-2023) & (US$ Million)
Table 51. Global Goose Parvovirus Antibodies Sales Market Share in Value by Application (2018-2023)
Table 52. Global Goose Parvovirus Antibodies Price by Application (2018-2023) & (US$/K Doses)
Table 53. Global Goose Parvovirus Antibodies Sales by Application (2024-2033) & (M Doses)
Table 54. Global Goose Parvovirus Antibodies Sales Market Share in Volume by Application (2024-2033)
Table 55. Global Goose Parvovirus Antibodies Sales by Application (2024-2033) & (US$ Million)
Table 56. Global Goose Parvovirus Antibodies Sales Market Share in Value by Application (2024-2033)
Table 57. Global Goose Parvovirus Antibodies Price by Application (2024-2033) & (US$/K Doses)
Table 58. North America Goose Parvovirus Antibodies Sales by Application (2018-2023) (M Doses)
Table 59. North America Goose Parvovirus Antibodies Sales by Application (2018-2023) & (US$ Million)
Table 60. Europe Goose Parvovirus Antibodies Sales by Application (2018-2023) (M Doses)
Table 61. Europe Goose Parvovirus Antibodies Sales by Application (2018-2023) & (US$ Million)
Table 62. Asia-Pacific Goose Parvovirus Antibodies Sales by Application (2018-2023) (M Doses)
Table 63. Asia-Pacific Goose Parvovirus Antibodies Sales by Application (2018-2023) & (US$ Million)
Table 64. Latin America Goose Parvovirus Antibodies Sales by Application (2018-2023) (M Doses)
Table 65. Latin America Goose Parvovirus Antibodies Sales by Application (2018-2023) & (US$ Million)
Table 66. Middle East and Africa Goose Parvovirus Antibodies Sales by Application (2018-2023) (M Doses)
Table 67. Middle East and Africa Goose Parvovirus Antibodies Sales by Application (2018-2023) & (US$ Million)
Table 68. North America Goose Parvovirus Antibodies Sales by Country (2018-2023) & (M Doses)
Table 69. North America Goose Parvovirus Antibodies Sales Market Share in Volume by Country (2018-2023)
Table 70. North America Goose Parvovirus Antibodies Sales by Country (2018-2023) & (US$ Million)
Table 71. North America Goose Parvovirus Antibodies Sales Market Share in Value by Country (2018-2023)
Table 72. North America Goose Parvovirus Antibodies Sales by Country (2024-2033) & (M Doses)
Table 73. North America Goose Parvovirus Antibodies Sales Market Share in Volume by Country (2024-2033)
Table 74. North America Goose Parvovirus Antibodies Sales by Country (2024-2033) & (US$ Million)
Table 75. North America Goose Parvovirus Antibodies Sales Market Share in Value by Country (2024-2033)
Table 76. Europe Goose Parvovirus Antibodies Sales by Country (2018-2023) & (M Doses)
Table 77. Europe Goose Parvovirus Antibodies Sales Market Share in Volume by Country (2018-2023)
Table 78. Europe Goose Parvovirus Antibodies Sales by Country (2018-2023) & (US$ Million)
Table 79. Europe Goose Parvovirus Antibodies Sales Market Share in Value by Country (2018-2023)
Table 80. Europe Goose Parvovirus Antibodies Sales by Country (2024-2033) & (M Doses)
Table 81. Europe Goose Parvovirus Antibodies Sales Market Share in Volume by Country (2024-2033)
Table 82. Europe Goose Parvovirus Antibodies Sales by Country (2024-2033) & (US$ Million)
Table 83. Europe Goose Parvovirus Antibodies Sales Market Share in Value by Country (2024-2033)
Table 84. Asia-Pacific Goose Parvovirus Antibodies Sales by Region (2018-2023) & (M Doses)
Table 85. Asia-Pacific Goose Parvovirus Antibodies Sales Market Share in Volume by Region (2018-2023)
Table 86. Asia-Pacific Goose Parvovirus Antibodies Sales by Region (2018-2023) & (US$ Million)
Table 87. Asia-Pacific Goose Parvovirus Antibodies Sales Market Share in Value by Region (2018-2023)
Table 88. Asia-Pacific Goose Parvovirus Antibodies Sales by Region (2024-2033) & (M Doses)
Table 89. Asia-Pacific Goose Parvovirus Antibodies Sales Market Share in Volume by Region (2024-2033)
Table 90. Asia-Pacific Goose Parvovirus Antibodies Sales by Region (2024-2033) & (US$ Million)
Table 91. Asia-Pacific Goose Parvovirus Antibodies Sales Market Share in Value by Region (2024-2033)
Table 92. Latin America Goose Parvovirus Antibodies Sales by Country (2018-2023) & (M Doses)
Table 93. Latin America Goose Parvovirus Antibodies Sales Market Share in Volume by Country (2018-2023)
Table 94. Latin America Goose Parvovirus Antibodies Sales by Country (2018-2023) & (US$ Million)
Table 95. Latin America Goose Parvovirus Antibodies Sales Market Share in Value by Country (2018-2023)
Table 96. Latin America Goose Parvovirus Antibodies Sales by Country (2024-2033) & (M Doses)
Table 97. Latin America Goose Parvovirus Antibodies Sales Market Share in Volume by Country (2024-2033)
Table 98. Latin America Goose Parvovirus Antibodies Sales by Country (2024-2033) & (US$ Million)
Table 99. Latin America Goose Parvovirus Antibodies Sales Market Share in Value by Country (2024-2033)
Table 100. Middle East and Africa Goose Parvovirus Antibodies Sales by Country (2018-2023) & (M Doses)
Table 101. Middle East and Africa Goose Parvovirus Antibodies Sales Market Share in Volume by Country (2018-2023)
Table 102. Middle East and Africa Goose Parvovirus Antibodies Sales by Country (2018-2023) & (US$ Million)
Table 103. Middle East and Africa Goose Parvovirus Antibodies Sales Market Share in Value by Country (2018-2023)
Table 104. Middle East and Africa Goose Parvovirus Antibodies Sales by Country (2024-2033) & (M Doses)
Table 105. Middle East and Africa Goose Parvovirus Antibodies Sales Market Share in Volume by Country (2024-2033)
Table 106. Middle East and Africa Goose Parvovirus Antibodies Sales by Country (2024-2033) & (US$ Million)
Table 107. Middle East and Africa Goose Parvovirus Antibodies Sales Market Share in Value by Country (2024-2033)
Table 108. Harbin Pharmaceutical Group Company Information
Table 109. Harbin Pharmaceutical Group Introduction and Business Overview
Table 110. Harbin Pharmaceutical Group Goose Parvovirus Antibodies Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 111. Harbin Pharmaceutical Group Goose Parvovirus Antibodies Product
Table 112. Harbin Pharmaceutical Group Recent Development
Table 113. Qilu Animal Health Products Factorys Company Information
Table 114. Qilu Animal Health Products Factorys Introduction and Business Overview
Table 115. Qilu Animal Health Products Factorys Goose Parvovirus Antibodies Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 116. Qilu Animal Health Products Factorys Goose Parvovirus Antibodies Product
Table 117. Qilu Animal Health Products Factorys Recent Development
Table 118. Liaoning Yikang Biological Company Information
Table 119. Liaoning Yikang Biological Introduction and Business Overview
Table 120. Liaoning Yikang Biological Goose Parvovirus Antibodies Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 121. Liaoning Yikang Biological Goose Parvovirus Antibodies Product
Table 122. Liaoning Yikang Biological Recent Development
Table 123. Henan Hou Yi Group Company Information
Table 124. Henan Hou Yi Group Introduction and Business Overview
Table 125. Henan Hou Yi Group Goose Parvovirus Antibodies Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 126. Henan Hou Yi Group Goose Parvovirus Antibodies Product
Table 127. Henan Hou Yi Group Recent Development
Table 128. Tianjin Ruipu Company Information
Table 129. Tianjin Ruipu Introduction and Business Overview
Table 130. Tianjin Ruipu Goose Parvovirus Antibodies Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 131. Tianjin Ruipu Goose Parvovirus Antibodies Product
Table 132. Tianjin Ruipu Recent Development
Table 133. Guangzhou geleite Biotechnology Company Information
Table 134. Guangzhou geleite Biotechnology Introduction and Business Overview
Table 135. Guangzhou geleite Biotechnology Goose Parvovirus Antibodies Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 136. Guangzhou geleite Biotechnology Goose Parvovirus Antibodies Product
Table 137. Guangzhou geleite Biotechnology Recent Development
Table 138. Key Raw Materials Lists
Table 139. Raw Materials Key Suppliers Lists
Table 140. Goose Parvovirus Antibodies Market Trends
Table 141. Goose Parvovirus Antibodies Market Drivers
Table 142. Goose Parvovirus Antibodies Market Challenges
Table 143. Goose Parvovirus Antibodies Market Restraints
Table 144. Goose Parvovirus Antibodies Distributors List
Table 145. Goose Parvovirus Antibodies Downstream Customers
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Goose Parvovirus Antibodies Product Picture
Figure 2. Global Goose Parvovirus Antibodies Market Size, 2018 VS 2022 VS 2033 (US$ Million)
Figure 3. Global Goose Parvovirus Antibodies Market Size Status and Outlook (2018-2033) & (US$ Million)
Figure 4. Global Goose Parvovirus Antibodies Sales Status and Outlook (2018-2033) & (M Doses)
Figure 5. Product Picture of AGP≥1:8
Figure 6. Global AGP≥1:8 Sales YoY Growth (2018-2033) & (M Doses)
Figure 7. Product Picture of AGP≥1:16
Figure 8. Global AGP≥1:16 Sales YoY Growth (2018-2033) & (M Doses)
Figure 9. Product Picture of AGP≥1:32
Figure 10. Global AGP≥1:32 Sales YoY Growth (2018-2033) & (M Doses)
Figure 11. Global Goose Parvovirus Antibodies Sales by Type (2018-2033) & (US$ Million)
Figure 12. Global Goose Parvovirus Antibodies Sales Market Share by Type in 2022 & 2033
Figure 13. North America Goose Parvovirus Antibodies Sales Market Share in Volume by Type in 2022
Figure 14. North America Goose Parvovirus Antibodies Sales Market Share in Value by Type in 2022
Figure 15. Europe Goose Parvovirus Antibodies Sales Market Share in Volume by Type in 2022
Figure 16. Europe Goose Parvovirus Antibodies Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Goose Parvovirus Antibodies Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Goose Parvovirus Antibodies Sales Market Share in Value by Type in 2022
Figure 19. Latin America Goose Parvovirus Antibodies Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Goose Parvovirus Antibodies Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Goose Parvovirus Antibodies Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Goose Parvovirus Antibodies Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Goose Parvovirus Antibodies Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Goose Parvovirus Antibodies Revenue in 2022
Figure 25. Goose Parvovirus Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Individual Farming
Figure 27. Global Individual Farming Sales YoY Growth (2018-2033) & (M Doses)
Figure 28. Product Picture of Medium and Large Farms
Figure 29. Global Medium and Large Farms Sales YoY Growth (2018-2033) & (M Doses)
Figure 30. Global Goose Parvovirus Antibodies Sales by Application (2018-2033) & (US$ Million)
Figure 31. Global Goose Parvovirus Antibodies Sales Market Share by Application in 2022 & 2033
Figure 32. North America Goose Parvovirus Antibodies Sales Market Share in Volume by Application in 2022
Figure 33. North America Goose Parvovirus Antibodies Sales Market Share in Value by Application in 2022
Figure 34. Europe Goose Parvovirus Antibodies Sales Market Share in Volume by Application in 2022
Figure 35. Europe Goose Parvovirus Antibodies Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Goose Parvovirus Antibodies Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Goose Parvovirus Antibodies Sales Market Share in Value by Application in 2022
Figure 38. Latin America Goose Parvovirus Antibodies Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Goose Parvovirus Antibodies Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Goose Parvovirus Antibodies Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Goose Parvovirus Antibodies Manufacturing Cost Structure
Figure 43. Goose Parvovirus Antibodies Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed